Is Imux a good stock to buy?
Is IMMUNIC Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: IMUX) stock is to Strong Buy IMUX stock.
Is Immunic stock a good buy?
Immunic has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Will Imux stock go up?
Stock Price Forecast The 7 analysts offering 12-month price forecasts for Immunic Inc have a median target of 57.00, with a high estimate of 71.00 and a low estimate of 25.00. The median estimate represents a +1,004.65% increase from the last price of 5.16.